We have recently demonstrated that miR-100 is under-expressed in 100% of low-grade, non-invasive bladder cancers, with FGFR3 as a putative target gene [5], representing a possible first step of tumorigenesis, before the typical FGFR3 mutation. This evidence concerns the gene FGFR3 and urinary bladder carcinoma.